Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
A transient Trilaciclib-mediated G1 cell-cycle arrest in CDK4/6-sensitive cells decreases the in vitro toxicity of a variety of commonly used cytotoxic chemotherapy agents associated with myelosuppression
PSI-7977 inhibits clone A (GT 1b) wild-type and S282T replicons with EC90 values of 0
CAS Number: 516480-79-8
09 mM) Ethanol 48 mg/mL (198
D-Glucose is a carbohydrate sweetener and critical components of the general metabolism
Vandetanib - CAS# 443913-73-3 CRABP-II Degrader-1 A transient Trilaciclib-mediated G1 cell-cycleVandetanib is an orally bioavailable 4 anilinoquinazoline. Vandetanib selectively inhibits the tyrosine kinase activity of vascular endothelial growth factor receptor 2 (VEGF2), thereby blocking VEGF stimulated endothelial cell proliferation and migration and reducing tumor vessel permeability. This agent also blocks the tyrosine kinase activity of epidermal growth factor receptor (EGFR), a receptor tyrosine kinase that mediates tumor cell
US$ 190.50
US$ 174.99
US$ 76.99
US$ 164.99
US$ 50.10
US$ 175.69
US$ 174.99